top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Comprehensive Cardiovascular Medicine in the Primary Care Setting / / edited by Peter P. Toth, Christopher P. Cannon
Comprehensive Cardiovascular Medicine in the Primary Care Setting / / edited by Peter P. Toth, Christopher P. Cannon
Edizione [2nd ed. 2019.]
Pubbl/distr/stampa Cham : , : Springer International Publishing : , : Imprint : Humana, , 2019
Descrizione fisica 1 online resource (XV, 536 p. 145 illus., 87 illus. in color.)
Disciplina 616.1
Collana Contemporary Cardiology
Soggetto topico Primary care (Medicine)
Cardiology
Primary Care Medicine
ISBN 3-319-97622-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Part I: Cardiovascular Risk Factors -- Epidemiologic Characterization of Risk for Cardiovascular Disease -- Risk Quantitation: 10-year and Lifetime Estimation -- Hypertension -- Dyslipidemia -- Obesity and Therapeutic Approaches to Weight Loss -- Inflammatory Markers and Novel Risk Factors -- Deciphering Cardiovascular Genomics and How They Apply to Cardiovascular Disease Prevention -- Metabolic Syndrome -- Type I Diabetes Mellitus -- Type 2 Diabetes Mellitus -- Chronic Kidney Disease -- Part II: Coronary Artery Disease -- Evaluation of Chest Pain and Myocardial Ischemia -- Unstable Angina and NSTEMI -- ST Segment Elevated Myocardial Infarction -- Coronary Artery Stenting -- Coronary Artery Bypass Grafting -- Cardiac Rehabilitation. -Part III: Peripheral Forms of Venous and Arterial Disease -- Carotid Artery Disease -- Peripheral Arterial Disease -- Deep Venous Thrombosis and Pulmonary Embolism -- Pulmonary Hypertension and Cor Pulmonale -- Management of Ischemic Cerebrovascular Accident -- Aortic Aneurysms -- Erectile Dysfunction -- Part IV: Cardiac Disease -- Cardiac Valvular Disease -- Pericardial Diseases -- Common Atrial and Ventricular Arrhythmias -- Congestive Heart Failure -- Part V: Cardiac Imaging -- Coronary Calcium Scoring -- Cardiac CT Angiography -- Cardiac MRI Imaging.
Record Nr. UNINA-9910337506103321
Cham : , : Springer International Publishing : , : Imprint : Humana, , 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Lipoproteins in Diabetes Mellitus / / edited by Alicia J. Jenkins, Peter P. Toth
Lipoproteins in Diabetes Mellitus / / edited by Alicia J. Jenkins, Peter P. Toth
Autore Jenkins Alicia J
Edizione [2nd ed. 2023.]
Pubbl/distr/stampa Cham : , : Springer International Publishing : , : Imprint : Humana, , 2023
Descrizione fisica 1 online resource (925 pages)
Disciplina 612.01575
Altri autori (Persone) TothPeter P
Collana Contemporary Diabetes
Soggetto topico Endocrinology
Blood-vessels - Diseases
Cardiology
Angiology
ISBN 3-031-26681-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Part 1 : Lipoprotein Metabolism, Qualitative Changes and Measurements -- 1. Laboratory Assessment of Lipoproteins in Type 2 Diabetes -- 2. Tools for Assessing Lipoprotein Metabolism in Diabetes Mellitus -- 3. Links Between Glucose and Lipoproteins -- 4. Apoproteins and Cell Surface Receptors Regulating Lipoprotein Metabolism in the Setting of Type 2 Diabetes -- 5. Lipoprotein metabolism and alterations induced by insulin resistance and diabetes -- 6. The PPAR system in diabetes -- 7. Production And Metabolism Of Triglyceride-Rich Lipoproteins: Impact Of Diabetes -- 8. Triglyceride- And Cholesterol-Rich Remnant Lipoproteins In Risk Of Cardiovascular Disease In Diabetes Mellitus -- 9. HDL Function In Diabetes -- 10. Lipoprotein (a): Metabolism, Pathophysiology and Impact on Diabetes Mellitus -- 11. Lipoprotein Glycation in Diabetes Mellitus -- 12. Lipid:Extracellular Matrix Interactions as Therapeutic Targets in the Atherosclerosis of Diabetes -- Part 2 : Lipoproteins and the Complications of Diabetes -- 13. The Role of Modified Forms of LDL and Corresponding Autoantibodies in the Development of Complications in Diabetes -- 14. Endothelial dysfunction in type 2 diabetes, with an update on new interventions -- 15. Lipoproteins and diabetic kidney disease -- 16. Lipids and Diabetic Retinopathy -- 17. Roles of Extravasated and Modified Plasma Lipoproteins in Diabetic Retinopathy -- 18. The Role Of Lipids And Lipoproteins In Peripheral Neuropathy -- 19. Lipoproteins and Ischemic Stroke in Diabetes -- Part 3 : Lipoprotein Treatment in Diabetes -- 20. About Randomized Clinical Trials Related to Lipoproteins in Diabetes Mellitus -- 21. Effects of Lifestyle (Diet, Plant Sterols, Exercise and Smoking) and Glycemic Control on Lipoproteins in Diabetes -- 22. Statin Therapy: Impact on Dyslipidemia and Cardiovascular Events in Patients with Diabetes -- 23. Statin intolerance – An overview for clinicians -- 24. Fibrate Therapy: Impact on Dyslipidemia and Cardiovascular Events in Patients with Diabetes Mellitus Type 2 -- 25. EPA and Mixed Omega-3 Fatty Acids: Impact on Dyslipidemia and Cardiovascular Events in Patients With Diabetes -- 26. Cholesterol Absorption Inhibitors (Ezetimibe) and Bile Acid Binding Resins (Colesevelam HCl) as Therapy for Dyslipidemia in Patients with Diabetes Mellitus -- 27. Clinical Efficacy Of Proprotein Convertase Synthase Kexin Type 9 Inhibition In Persons With Diabetes Mellitus -- 28. Clinical Care of Lipids in People with Type 1 diabetes -- 29. Adjunct drug treatment to reduce vascular disease in people with diabetes -- 30. Emerging lipoprotein-related therapeutics for patients with diabetes -- Part 4 : Epidemiology of Diabetes and Diabetic Dyslipidemia -- 31. Diabetes Epidemiology And Its Implications -- 32. Epidemiology, Control, and Cardiovascular Outcomes of Dyslipidemia in Diabetes.
Record Nr. UNINA-9910731468903321
Jenkins Alicia J  
Cham : , : Springer International Publishing : , : Imprint : Humana, , 2023
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Lipoproteins in Diabetes Mellitus / / edited by Alicia J. Jenkins, Peter P. Toth, Timothy J. Lyons
Lipoproteins in Diabetes Mellitus / / edited by Alicia J. Jenkins, Peter P. Toth, Timothy J. Lyons
Edizione [1st ed. 2014.]
Pubbl/distr/stampa New York, NY : , : Springer New York : , : Imprint : Humana, , 2014
Descrizione fisica 1 online resource (468 p.)
Disciplina 616.4
616.4/62
616.462
Collana Contemporary Diabetes
Soggetto topico Endocrinology
Blood-vessels - Diseases
Cardiology
Angiology
ISBN 1-4614-7554-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Laboratory Assessment of Lipoproteins in Diabetes -- Lipoprotein Subclasses and Cardiovascular Disease Risk in Insulin Resistance Diabetes --  Insulin Resistance and Atherosclerosis --  Apoproteins and Cell Surface Receptors Regulating Lipoprotein Metabolism in the Setting of Type 2 Diabetes -- Lipoprotein Metabolism and Alterations induced by insulin resistance and diabetes -- Production and Metabolism of Triglyceride-Rich Lipoproteins in both the Normal and Diabetic States -- Lipoprotein(a): Structure, Metabolism and Pathophysiology -- Lipoprotein Glycation in Diabetes Mellitus.-Lipoprotein (LDL and  HDL) Oxidation in Diabetes Mellitus -- The Role of Modified Forms of LDL and Corresponding Autoantibodies in the Development of Complications in Diabetes -- Lipid – Extracellular Matrix Interactions as Therapeutic Targets in the Atherosclerosis of Diabetes -- Tools for Assessing Lipoprotein Metabolism in Diabetes Mellitus -- Endothelial Dysfunction and Dyslipidaemia in Type 2 Diabetes: Pathogenesis, Significance and Therapy -- Lipoproteins and Diabetic Nephropathy -- Roles of Extravasated and Modified Plasma Lipoproteins in Diabetic Retinopathy -- Effects of Lifestyle (Diet, Plant Sterols, Excercise) and Glycemic Control on Lipoporteins in Diabetes -- About Randomised Clinical Trials Related to Lipoproteins in Diabetes Mellitus -- Statin Therapy: Impact on Dyslipidemia and Cardiovascular Events in Diabetic Patients -- The PPAR System in Diabetes -- Fibrate Therapy: Impact on Dyslipidemia and Cardiovascular Events in Diabetic Patients -- Niacin Therapy: Impact on Dyslipidemia and Cardiovascular Events in Diabetic Patients -- Cholesterol Absorption Inhibitors (Ezetimibe) and Bile Acid Binding Resins (Colesevelam HCl) as Therapy for Dyslipidemia in Patients with Diabetes Mellitus -- Emerging Lipoprotein-Related Therapeutics for Patients with Diabetes.
Record Nr. UNINA-9910300088703321
New York, NY : , : Springer New York : , : Imprint : Humana, , 2014
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui